Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · IEX Real-Time Price · USD
25.57 -0.13 (-0.51%)
Jan 21, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202020192018201720162015201420132012
Revenue
198.32175.34164.25154.94133.5999.8928.200
Revenue Growth (YoY)
13.11%6.75%6.01%15.98%33.74%254.19%---
Cost of Revenue
6.135.235.533.614.552.190.5700
Gross Profit
192.2170.1158.72151.33129.0497.7127.6300
Selling, General & Admin
135.8128.95103.65101.3391.9479.5459.6517.6929.59
Research & Development
131.77140.96123.7678.1770.8250.4347.87.080.66
Other Operating Expenses
97.137.5-0.246.236.114.71000
Operating Expenses
364.7277.41227.17185.73168.87134.68107.4424.7730.26
Operating Income
-172.51-107.31-68.45-34.4-39.83-36.97-79.81-24.77-30.26
Interest Expense / Income
19.0518.839.814.424.737.757.440.050.08
Other Expense / Income
-2.7720.3123.6119.5413.02-150.1926.169.730
Pretax Income
-188.79-146.45-101.87-58.36-57.58105.47-113.4-34.55-30.34
Income Tax
-19.36-0.020.811.37-9.68-11.77-2.460.080
Net Income
-169.43-146.43-102.68-59.73-47.9117.24-110.94-34.63-30.34
Net Income Common
-169.43-146.43-102.68-59.73-47.9117.24-110.94-34.63-30.34
Shares Outstanding (Basic)
48424039373425144
Shares Outstanding (Diluted)
48424039383825144
Shares Change
12.28%4.72%4.29%1.26%1.88%49.98%76.40%287.90%-
EPS (Basic)
-3.56-3.46-2.54-1.54-1.293.49-4.43-2.44-8.29
EPS (Diluted)
-3.56-3.46-2.54-1.54-1.293.17-4.43-2.44-8.29
Free Cash Flow Per Share
-1.04-1.38-0.640.17-0.13-0.04-1.86-1.25-0.75
Gross Margin
96.91%97.01%96.63%97.67%96.59%97.81%97.98%--
Operating Margin
-86.98%-61.20%-41.68%-22.20%-29.82%-37.01%-282.98%--
Profit Margin
-85.43%-83.51%-62.51%-38.55%-35.86%117.36%-393.36%--
Free Cash Flow Margin
-24.96%-33.31%-15.64%4.21%-3.64%-1.41%-164.92%--
Effective Tax Rate
10.25%0.01%-0.80%-2.34%16.81%-11.16%2.17%-0.22%0.00%
EBITDA
-143.95-107.16-72.93-36.14-36.71126.61-100.56-34.29-30.13
EBITDA Margin
-72.59%-61.11%-44.40%-23.32%-27.48%126.74%-356.56%--
EBIT
-169.74-127.62-92.06-53.94-52.85113.22-105.96-34.5-30.26
EBIT Margin
-85.59%-72.79%-56.05%-34.81%-39.56%113.34%-375.72%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).